HZNP - Horizon Therapeutics PLC (HZNP) CEO Tim Walbert on Q4 2021 Results - Earnings Call Transcript
Horizon Therapeutics PLC (HZNP) Q4 2021 Results Conference Call March 01, 2022 08:00 AM ET Company Participants Tina Ventura - SVP, IRO Tim Walbert - Chairman, President, CEO Elizabeth Thompson - EVP, Research & Development Paul Hoelscher - EVP, CFO Conference Call Participants Akash Tewari - Jefferies Annabel Samimy - Stifel Chris Schott - JPMorgan David Amsellem - Piper Sandler Gary Nachman - BMO Capital Jason Gerberry - Bank of America Ken Cacciatore - Cowen Madhu Kumar - Goldman Sachs Michael Ulz - Martin Stanley Presentation Operator Good morning, and thank you for standing by. Welcome to the Horizon Therapeutics Fourth Quarter and Full Year 2021 Earnings Conference Call. As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President and Investor Relations Officer. Tina Ventura Thank you, Olivia. Good morning, everyone, and thank you for joining us. On the
For further details see:
Horizon Therapeutics PLC (HZNP) CEO Tim Walbert on Q4 2021 Results - Earnings Call Transcript